Intravaginal administration of RU 486 in humans and rats: Inadequate absorption in humans

O. Heikinheimo, H. Croxatto, A. M. Salvatierra, C. C. Chang, T. Luukkainen, P. Lähteenmäki

Resultado de la investigación: Contribución a una revistaArtículorevisión exhaustiva

11 Citas (Scopus)

Resumen

Vaginal absorption of the antiprogesterone steroid RU 486 was studied in humans and rat. In rats, RU 486 was sufficiently absorbed to terminate early pregnancy following vaginal, oral or intramuscular administration. The quantitation of RU 486 in serum showed that the ratios of the areas under the coocentration curves per mg administered were 1:2.8:3.4 for the vaginal, intramuscular and oral routes, respectively. Female voluteers received RU 486 vaginally in polyethylene glycol (PEG) suppositories, In tampons and in oil solution. Following vaginal (PEG-suppository) and oral a administration of 100 mg of RU 486, the ratio of the areas under the serum concentration curves was 1:56, respectively. From tampons and oil, RU 486 was absorbed in a similar manner to that of the PEG-suppositories, resulting in nanomolar serum concentrations. In humans no biological effects were noted following vaginal administration of RU 486. These data suggest that vaginal release of RU 486 is not a successful route of administration in humans.

Idioma originalInglés
Páginas (desde-hasta)645-648
Número de páginas4
PublicaciónHuman Reproduction
Volumen2
N.º8
DOI
EstadoPublicada - 1 ene 1987

Áreas temáticas de ASJC Scopus

  • Medicina reproductiva
  • Rehabilitación
  • Ginecología y obstetricia

Huella

Profundice en los temas de investigación de 'Intravaginal administration of RU 486 in humans and rats: Inadequate absorption in humans'. En conjunto forman una huella única.

Citar esto